Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P McLaughlin

Showing results (521-530 of 726) with videos related to

Pageof 73
Sort By:
Cancer Research|October 1, 1988
Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphomaF Cabanillas, S Pathak, J Trujillo, et al.
Brain, Behavior, and Immunity|March 5, 2026
The role of NLRP3 inflammasome in opioid-induced neurochemical markers, therapeutic effects, and adverse effects in male miceMyosotys Rodriguez, Dileepkumar Veeragoni, Candy Carbajal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
The effects of repetitive haemarthrosis on postural balance in children with haemophiliaF M B Souza, P McLaughlin, R P Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphomaP McLaughlin, F B Hagemeister, F Swan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphomaC Hosing, R M Saliba, P McLaughlin, et al.
Investigational New Drugs|January 19, 2000
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combinationJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.
Blood|June 1, 1988
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyteF Cabanillas, S Pathak, J Trujillo, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1983
High-dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphomaN M Tannir, G Spitzer, A R Zander, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyF B Hagemeister, R Purugganan, D A Podoloff, et al.
The American Journal of Cardiology|June 15, 1994
Hemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery diseaseD P McLaughlin, G A Beller, J Linden, et al.
Pageof 73

Showing results (521-530 of 726) with videos related to

Sort By:
Pageof 73
Cancer Research|October 1, 1988
Frequent nonrandom chromosome abnormalities in 27 patients with untreated large cell lymphoma and immunoblastic lymphomaF Cabanillas, S Pathak, J Trujillo, et al.
Brain, Behavior, and Immunity|March 5, 2026
The role of NLRP3 inflammasome in opioid-induced neurochemical markers, therapeutic effects, and adverse effects in male miceMyosotys Rodriguez, Dileepkumar Veeragoni, Candy Carbajal, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 29, 2013
The effects of repetitive haemarthrosis on postural balance in children with haemophiliaF M B Souza, P McLaughlin, R P Pereira, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1994
Phase I study of the combination of fludarabine, mitoxantrone, and dexamethasone in low-grade lymphomaP McLaughlin, F B Hagemeister, F Swan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 19, 2003
Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphomaC Hosing, R M Saliba, P McLaughlin, et al.
Investigational New Drugs|January 19, 2000
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combinationJ E Romaguera, M A Rodriguez, F B Hagemeister, et al.
Blood|June 1, 1988
Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyteF Cabanillas, S Pathak, J Trujillo, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1983
High-dose chemoradiotherapy and bone marrow transplantation in patients with refractory lymphomaN M Tannir, G Spitzer, A R Zander, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyF B Hagemeister, R Purugganan, D A Podoloff, et al.
The American Journal of Cardiology|June 15, 1994
Hemodynamic and metabolic correlates of dipyridamole-induced myocardial thallium-201 perfusion abnormalities in multivessel coronary artery diseaseD P McLaughlin, G A Beller, J Linden, et al.
Pageof 73